Insider Transactions in Q3 2023 at Agios Pharmaceuticals, Inc. (AGIO)
Insider Transaction List (Q3 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 28
2023
|
Cecilia Jones Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
2,179
-18.54%
|
$52,296
$24.79 P/Share
|
|
Sep 26
2023
|
Cecilia Jones Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,472
+38.86%
|
-
|
|
Aug 17
2023
|
James William Burns Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
6,395
-21.12%
|
$166,270
$26.28 P/Share
|
|
Aug 11
2023
|
Rahul D. Ballal Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,302
+50.0%
|
-
|
|
Aug 11
2023
|
Cynthia Smith Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,302
+50.0%
|
-
|
|
Aug 09
2023
|
Kaye I Foster Cheek Director |
SELL
Open market or private sale
|
Direct |
25,000
-68.45%
|
$625,000
$25.96 P/Share
|
|
Aug 09
2023
|
Kaye I Foster Cheek Director |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+40.63%
|
$450,000
$18.09 P/Share
|
|
Aug 08
2023
|
Brian Goff Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
10,178
-27.68%
|
$254,450
$25.48 P/Share
|
|
Aug 08
2023
|
Brian Goff Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
22,691
+38.16%
|
-
|
|
Aug 07
2023
|
Theodore James Washburn Jr. Principal Accounting Officer |
SELL
Open market or private sale
|
Direct |
2,918
-51.56%
|
$72,950
$25.39 P/Share
|
|
Aug 01
2023
|
Theodore James Washburn Jr. Principal Accounting Officer |
SELL
Open market or private sale
|
Direct |
1,232
-17.88%
|
$32,032
$26.26 P/Share
|
|
Aug 01
2023
|
Theodore James Washburn Jr. Principal Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,150
+37.59%
|
-
|